Pierre Ellul

Prof. Pierre Ellul

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
PVPablo Cortegoso Valdivia
Pablo Cortegoso Valdivia
Karolina Skonieczna-ŻydeckaKarolina Skonieczna-Żydecka
Karolina Skonieczna-Żydecka
AEAlfonso ELOSUA
Alfonso ELOSUA
MSMartina Sciberras
Martina Sciberras
SPStefania Piccirelli
Stefania Piccirelli
Anastasios KoulaouzidisAnastasios Koulaouzidis
Anastasios Koulaouzidis
Background: Capsule endoscopy (CE) has become a widespread modality for non-invasive evaluation of the gastrointestinal (GI) tract, with several CE models having been developed throughout the years. The aim of this systematic review and meta-analysis is to evaluate performance measures such as completion, detection and retention rates of CE. Methods: Literature through to August 2021 was screened for articles regarding all capsule types: small bowel, double-headed capsule for the colon or PillCam®Crohn’s capsule, magnetically-controlled capsule endoscopy, esophageal capsule and patency capsule. Primary outcomes included detection rate (DR), completion rate (CR) and capsule retention rate (RR). DR, CR and RR were also analyzed in relation to indications such as obscure GI bleeding (OGIB), known/suspected Crohn’s disease (CD), celiac disease (CeD), neoplastic lesions (NL) and clinical symptoms (CS). Results: 328 original articles involving 86,930 patients who underwent CE were included. OGIB was the most common indication (n = 44,750), followed by CS (n = 17,897), CD (n = 11,299), NL (n = 4989) and CeD (n = 947). The most used capsule type was small bowel CE in 236 studies. DR, CR and RR for all indications were 59%, 89.6% and 2%, respectively. According to specific indications: DR were 55%, 66%, 63%, 52% and 62%; CR were 90.6%, 86.5%, 78.2%, 94% and 92.8%; and RR were 2%, 4%, 1%, 6% and 2%. Conclusions: Pooled DR, CR and RR are acceptable for all capsule types. OGIB is the most common indication for CE. Technological advancements have expanded the scope of CE devices in detecting GI pathology with acceptable rates for a complete examination.

18 January 2016 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
PEPierre Ellul
Pierre Ellul
SZStephania Chectuti Zammit
Stephania Chectuti Zammit
KKKonstantinos H. Katsanos
Konstantinos H. Katsanos
MCMonica Cesarini
Monica Cesarini
MAMariangela Allocca
Mariangela Allocca
GMGerassimos Mantzaris
Gerassimos Mantzaris
Introduction and Aims: Inflammatory Bowel diseases affects female patients almost exclusively during their reproductive age.Lack of education and misconceptions regarding the effect of disease and/or treatment on reproductive outcome may lead to voluntary childless and/or development of cervical pathologies. Aims: To assess the perspectives of IBD patients on fertility, pregnancy and its outcomes, and lactation as well as their awareness of HPV-related pathologies and screening for cervical cancer. Methods: This prospective study was performed across 9 different Mediterranean IBD Centers between 2014 and 2015 and included consecutive female IBD between the age of 16 and 50 years. All patients responded to a questionnaire based on ECCO guidelines. Results: Three hundred and forty-eight IBD patients (mean age of 37.4 (SD±2.1) years) were recruited. A significant proportion of patients (>60%) were afraid that IBD may lead to a complicated pregnancy and that the disease itself and/or its medications can cause foetal harm. Patients had similar concerns that IBD can be transmitted to their offsprings as well as with regards to breastfeeding. Counselling from health care professionals was associated positively with the highest number of pregnancies and inversely with the lowest number of patients who considered voluntary childlessness (p<0.0001). Patients with a higher level of education were more likely to get pregnant (p- 0.004). There was a low uptake of the HPV vaccine but a good uptake of cervical cancer screening. Conclusion: This data demonstrates a low penetration of the current European guidelines. A better and different multi-disciplinary approach may be required to improve patient education.

2 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
PVPablo Cortegoso Valdivia
Pablo Cortegoso Valdivia
UDUlrik Deding
Ulrik Deding
TBThomas Bjørsum-Meyer
Thomas Bjørsum-Meyer
GBgunnar baatrup
gunnar baatrup
IFIgnacio Fernández-Urién
Ignacio Fernández-Urién
Anastasios KoulaouzidisAnastasios Koulaouzidis
Anastasios Koulaouzidis
Video-capsule endoscopy (VCE) reading is a time- and energy-consuming task. Agreement on findings between readers (either different or the same) is a crucial point for increasing performance and providing valid reports. The aim of this systematic review with meta-analysis is to provide an evaluation of inter/intra-observer agreement in VCE reading. A systematic literature search in PubMed, Embase and Web of Science was performed throughout September 2022. The degree of observer agreement, expressed with different test statistics, was extracted. As different statistics are not directly comparable, our analyses were stratified by type of test statistics, dividing them in groups of “None/Poor/Minimal”, “Moderate/Weak/Fair”, “Good/Excellent/Strong” and “Perfect/Almost perfect” to report the proportions of each. In total, 60 studies were included in the analysis, with a total of 579 comparisons. The quality of included studies, assessed with the MINORS score, was sufficient in 52/60 studies. The most common test statistics were the Kappa statistics for categorical outcomes (424 comparisons) and the intra-class correlation coefficient (ICC) for continuous outcomes (73 comparisons). In the overall comparison of inter-observer agreement, only 23% were evaluated as “good” or “perfect”; for intra-observer agreement, this was the case in 36%. Sources of heterogeneity (high, I2 81.8–98.1%) were investigated with meta-regressions, showing a possible role of country, capsule type and year of publication in Kappa inter-observer agreement. VCE reading suffers from substantial heterogeneity and sub-optimal agreement in both inter- and intra-observer evaluation. Artificial-intelligence-based tools and the adoption of a unified terminology may progressively enhance levels of agreement in VCE reading.

18 September 2018 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
PDF file
SSShaji Sebastian
Shaji Sebastian
CBChristopher Black
Christopher Black
DPDaniela Pugliese
Daniela Pugliese
AAAlessandro Armuzzi
Alessandro Armuzzi
Kapil SahnanKapil Sahnan
Kapil Sahnan
GFGionata Fiorino
Gionata Fiorino
Summary: Background: Treatment paradigms for Crohn′s disease with perianal fistulae (CD‐pAF) are evolving.Aims: To study the impact of multimodality treatment in CD‐pAF on recurrence rates and the need for re‐interventions and to identify predictive factors for these outcomes.Methods: This was a multinational multicentre retrospective cohort study. Multimodality approach was defined as using a combination of medical treatments (anti‐TNFs ± immunomodulators ± antibiotics) along with surgical approach (examination under anaesthesia (EUA) ± seton drainage) at diagnosis of CD‐pAF. Univariable and multivariable analyses were performed for variables indicative of the need for reintervention.Results: A total of 253 patients were included. 65% of patients received multimodality approach. Multimodality treatment resulted in complete fistula healing in 52% of patients. Re‐intervention was needed in 27% of patients with simple and in 40.3% of those with complex fistula. On multivariable analysis multimodality treatment (OR: 0.35, 95% CI: 0.17‐0.57, P = 0.001), seton removal (OR: 0.090, 95% CI: 0.027‐0.30, P = 0.0001, therapy with infliximab (OR: 0.19, 95% CI: 0.06‐0.64, P = 0.007), and therapy with adalimumab (OR: 0.12, "95% CI: 0.026‐0.56, P = 0.007) were predictive of avoiding repeat surgery. Proctitis (OR: 3.76, 95% CI: 1.09‐12.96, P = 0.03) was predictive of the need for radical surgery (proctectomy, diverting stoma) while multimodality treatment reduced the need for radical surgery (OR: 0.21, 95% CI: 0.05‐0.81, P = 0.02).Conclusions: Multimodality treatment, anti‐TNFs use, and removal of setons after multimodality treatment can result in improved outcomes in CD patients with perianal fistulae and reduce the need for repeat surgery and radical surgery.

31 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Mariangela AlloccaMariangela Allocca
Mariangela Allocca
MCMaría Chaparro
María Chaparro
HGHaidee Aleman Gonzalez
Haidee Aleman Gonzalez
MBMarta Maia Bosca-Watts
Marta Maia Bosca-Watts
CPCarolina Palmela
Carolina Palmela
GFGionata Fiorino
Gionata Fiorino
The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled in the study. The cumulative incidence of SARS-CoV-2 infection in patients with IBD vs. the general population was 0.406% and 0.402% cases, respectively. Twenty-three patients (24%) were hospitalized, 21 (22%) had pneumonia, four (4%) were admitted to the Intensive Care Unit, and one patient died. Lethality in our cohort was 1% compared to 9% in the general population. At multivariable analysis, age > 65 years was associated with increased risk of pneumonia and hospitalization (OR 11.6, 95% CI 2.18–62.60; OR 5.1, 95% CI 1.10–23.86, respectively), treatment with corticosteroids increased the risk of hospitalization (OR 7.6, 95% CI 1.48–40.05), whereas monoclonal antibodies were associated with reduced risk of pneumonia and hospitalization (OR 0.1, 95% CI 0.04–0.52; OR 0.3, 95% CI 0.10–0.90, respectively). The risk of COVID-19 in patients with IBD is similar to the general population. National lockdown was effective in preventing infection in our cohort. Advanced age and treatment with corticosteroids impacted negatively on the outcome of COVID-19, whereas monoclonal antibodies did not seem to have a detrimental effect.

21 October 2020
Verified
Open access
NPNaomi Piscopo
Naomi Piscopo
PEPierre Ellul
Pierre Ellul
Diverticular disease is common condition globally, especially in Western countries. Diverticulitis, Symptomatic uncomplicated Diverticular disease and Segmental Colitis associated with diverticula constitute diverticular disease. Although most patients with diverticula are asymptomatic, around 25% of patients will experience symptoms whilst 5% of patients have an episode of acute diverticulitis.